News / Spectrum

CDKL5 gene; cerebrospinal fluid; drug combo for fragile X syndrome

Here is a roundup of autism-related news and research spotted around the web for the week of 16 September.

By Jill Adams
17 September 2024 | 2 min read
comments
https://doi.org/10.53053/ZLVB8184 https://doi.org/10.53053/ZLVB8184 - opens a new tab Cite this article
  • Mice missing one or both copies of the gene CDKL5, which causes CDKL5 deficiency disorder in people, display autism-like traits as early as 2 weeks of age. Autism Research
  • Sensorimotor skills in infants predict self-regulation skills at 12 to 15 months old, and self-regulation skills in infants with autistic siblings predict autism traits at age 3. Developmental Science
  • Autism-linked genes can converge on downstream targets, and convergent effects are more prominent in mature glutamatergic neurons than in neural progenitor cells or GABA-ergic neurons, according to a preprint. bioRxiv
  • Microglia grown from an autistic person’s stem cells and missing the autism-linked gene NRXN1 actively release the proinflammatory cytokine IL-6 and fail to form functional neuronal networks. Brain, Behavior, and Immunity
Research image of microglia.
Uncurbed growth: Microglia missing the NRXN1 gene (right panel) proliferate more (pink stain) than control cells (left panel).
  • Some alterations in resting-state electroencephalograms are shared between people with autism and those with fragile X syndrome, whereas others distinguish the conditions. Journal of Neurodevelopmental Disorders
  • “The complexity of the 16p12.1 deletion and other genomic disorders calls for personalized medicine approaches that fully account for individual-level phenotypic presentation, family history, and genome-wide variant profile towards counseling, management, and potential treatment.” medRxiv
  • The composition of cerebrospinal fluid in embryonic mice is altered in the maternal immune activation mouse model of autism. Journal of Biological Chemistry
  • Combination therapy with lovastatin and minocycline decrease neuronal excitability in people with fragile X syndrome, according to a clinical trial. Spectrum covered earlier results with this drug combination in 2018. Autism Research

Sign up for the weekly Spectrum newsletter.

Stay current with the latest advancements in autism research.

Recommended reading

Research image of neural pluripotent stem cells.
Spectrum

Dosage of X or Y chromosome relates to distinct outcomes; and more

By Daisy Yuhas
24 June 2025 | 2 min read
Two paper arrows intersect to form a double helix.
Spectrum Microphone

Genetic background steers PTEN syndrome traits

By Holly Barker
19 June 2025 | 5 min listen
Research image of organoids from autistic people.
Spectrum

Altered visual processing in a mouse model of fragile X syndrome; and more

By Jill Adams
17 June 2025 | 2 min read

Explore more from The Transmitter

Astrocytes Microphone

Astrocytes sense neuromodulators to orchestrate neuronal activity and shape behavior

By Claudia López Lloreda
27 June 2025 | 9 min listen
Publishing

Authors correct image errors in Neuron paper that challenged microglia-to-neuron conversion

By Shaena Montanari
26 June 2025 | 3 min read
Community

Building a climate neuroscience subfield: Q&A with Angie Michaiel

By Calli McMurray
26 June 2025 | 5 min read